Transitional community adherence support for people leaving incarceration in South Africa: a pragmatic, open-label, randomised controlled trial

被引:1
|
作者
Mabuto, Tonderai [1 ,9 ]
Woznica, Daniel M. [2 ]
Ndini, Pretty [1 ]
Moyo, Derrick
Abraham, Munazza [3 ]
Hanrahan, Colleen [6 ]
Charalambous, Salome [1 ,4 ]
Zack, Barry [5 ]
Baral, Stefan [6 ]
Owczarzak, Jill [7 ]
Hoffmann, Christopher J. [4 ,8 ]
机构
[1] Aurum Inst, Dept Implementat Res, Johannesburg, South Africa
[2] Soc Crit Care Med, Mt Prospect, IL USA
[3] Univ Maryland, Dept Psychol, College Pk, MD USA
[4] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa
[5] Bridging Grp, Oakland, CA USA
[6] Johns Hopkins Univ, Sch Med, Dept Epidemiol, Baltimore, MD USA
[7] Johns Hopkins Univ, Sch Med, Dept Hlth Behav & Soc, Baltimore, MD USA
[8] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[9] Aurum Inst, Dept Implementat Res, ZA-2197 Johannesburg, South Africa
来源
LANCET HIV | 2024年 / 11卷 / 01期
关键词
HIV CARE CONTINUUM; PRISON; RELEASE; IMPROVE;
D O I
10.1016/S2352-3018(23)00235-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background People released from correctional facilities face multifactorial barriers to continuing HIV treatment. We hypothesised that barriers faced in the first 6 months of community re-entry would be decreased by a multilevel group-based and peer-led intervention, the Transitional Community Adherence Club (TCAC). Methods We did a pragmatic, open-label, individually randomised controlled trial in five correctional facilities in Gauteng, South Africa. Participants aged 18 years and older and receiving antiretroviral therapy (ART) in correctional facilities were enrolled before release and randomly assigned (1:2) to either passive referral (usual care) or TCACs. TCACs followed a 12-session curriculum over 6 months and were facilitated by trained peer and social workers. Participants were followed up by telephone and in person to assess the primary outcome: post-release enrolment in HIV treatment services at 6 months from the date of release. We did an intention-to-treat analysis to determine the effectiveness of TCACs compared with usual care. The trial was registered with the South African National Clinical Trials Register (DOH-27-0419-605) and ClinicalTrials.gov (NCT03340428). This study is completed and is listed as such on ClinicalTrials.gov. Findings From March 1, to Dec 13, 2019, we screened 222 individuals and enrolled 176 participants who were randomly assigned 1:2 to the usual care group (n=59) or TCACs (n=117). 175 participants were included in the final analysis. In the usual care group, 21 (36%) of 59 participants had enrolled in HIV treatment services at 6 months, compared with 71 (61%) of 116 in the TCAC group (risk ratio 1 center dot 7, 95% CI 1 center dot 2-2 center dot 5; p=0 center dot 0010). No adverse events were reported. Interpretation We found strong evidence that a differentiated service delivery model with curriculum and peer support designed specifically to address the needs of people with HIV returning from incarceration improved the primary outcome of enrolment in HIV treatment services. Our approach is a reasonable model to build further HIV treatment continuity interventions for individuals in the criminal justice system in South Africa and elsewhere.
引用
收藏
页码:e11 / e19
页数:9
相关论文
共 50 条
  • [31] Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial
    Vaglio, Augusto
    Palmisano, Alessandra
    Alberici, Federico
    Maggiore, Umberto
    Ferretti, Stefania
    Cobelli, Rocco
    Ferrozzi, Francesco
    Corradi, Domenico
    Salvarani, Carlo
    Buzio, Carlo
    LANCET, 2011, 378 (9788): : 338 - 346
  • [32] Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial
    Goya, Maria
    Pratcorona, Laia
    Merced, Carme
    Rodo, Carlota
    Valle, Leonor
    Romero, Azahar
    Juan, Miquel
    Rodriguez, Alberto
    Munoz, Begona
    Santacruz, Belen
    Bello-Munoz, Juan Carlos
    Llurba, Elisa
    Higueras, Teresa
    Cabero, Luis
    Carreras, Elena
    LANCET, 2012, 379 (9828): : 1800 - 1806
  • [33] FLUID trial: a protocol for a hospital-wide open-label cluster crossover pragmatic comparative effectiveness randomised pilot trial
    McIntyre, Lauralyn
    Taljaard, Monica
    McArdle, Tracy
    Fox-Robichaud, Alison
    English, Shane W.
    Martin, Claudio
    Marshall, John
    Menon, Kusum
    Muscedere, John
    Cook, Deborah J.
    Weijer, Charles
    Saginur, Raphael
    Maybee, Alies
    Iyengar, Akshai
    Forster, Alan
    Graham, Ian D.
    Hawken, Steven
    McCartney, Colin
    Seely, Andrew Je
    Stiell, Ian G.
    Thavorn, Kednapa
    Fergusson, Dean A.
    BMJ OPEN, 2018, 8 (08):
  • [34] Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open-label randomised controlled trial
    Kaura, Amit
    Sztriha, Laszlo
    Chan, Fong Kum
    Aeron-Thomas, John
    Gall, Nicholas
    Piechowski-Jozwiak, Bartlomiej L.
    Teo, James T.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2019, 24 (1)
  • [35] Open-label placebo treatment of women with premenstrual syndrome: study protocol of a randomised controlled trial
    Nascimento, Antje Frey
    Gaab, Jens
    Kirsch, Irving
    Kossowsky, Joe
    Meyer, Andrea
    Locher, Cosima
    BMJ OPEN, 2020, 10 (02):
  • [36] Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open-label randomised controlled trial
    Amit Kaura
    Laszlo Sztriha
    Fong Kum Chan
    John Aeron-Thomas
    Nicholas Gall
    Bartlomiej Piechowski-Jozwiak
    James T. Teo
    European Journal of Medical Research, 24
  • [37] Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial
    Tripura, Rupam
    von Seidlein, Lorenz
    Sovannaroth, Siv
    Peto, Thomas J.
    Callery, James J.
    Sokha, Meas
    Ean, Mom
    Heng, Chhouen
    Conradis-Jansen, Franca
    Madmanee, Wanassanan
    Peerawaranun, Pimnara
    Waithira, Naomi
    Khonputsa, Panarasri
    Jongdeepaisal, Monnaphat
    Pongsoipetch, Kulchada
    Chotthanawathit, Paphapisa
    Soviet, Ung
    Pell, Christopher
    Duanguppama, Jureeporn
    Rekol, Huy
    Tarning, Joel
    Imwong, Mallika
    Mukaka, Mavuto
    White, Nicholas J.
    Dondorp, Arjen M.
    Maude, Richard J.
    LANCET INFECTIOUS DISEASES, 2023, 23 (01): : 81 - 90
  • [38] Open-label placebo for insomnia (OPIN): study protocol for a cohort multiple randomised controlled trial
    Colagiuri, Ben
    Sharpe, Louise
    Ambarchi, Zahava
    Glozier, Nick
    Bartlett, Delwyn
    Costa, Daniel S. J.
    Scott, Amelia
    BMJ OPEN, 2021, 11 (02):
  • [39] Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial
    Biere, Surya S. A. Y.
    Henegouwen, Mark I. van Berge
    Maas, Kirsten W.
    Bonavina, Luigi
    Rosman, Camiel
    Roig Garcia, Josep
    Gisbertz, Suzanne S.
    Klinkenbijl, Jean H. G.
    Hollmann, Markus W.
    de lange, Elly S. M.
    Bonjer, H. Jaap
    van der Peet, Donald L.
    Cuesta, Miguel A.
    LANCET, 2012, 379 (9829): : 1887 - 1892
  • [40] Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial
    Khan, Omar
    Nizar, Shiyam
    Vasilikostas, Georgios
    Wan, Andrew
    JOURNAL OF THORACIC DISEASE, 2012, 4 (05) : 465 - 466